AAPL 195.95 -0.4 (-0.20%)MSFT 133.45 +0.52 (+0.39%)FB 188.78 +0.08 (+0.04%)ZNGA 5.91 -0.04 (-0.59%)NVDA 151.96 -0.17 (-0.11%)WBA 53.16 +0.06 (+0.12%)GOOG 1086.06 +0.02 (+0.00%)PIH 5.3 0 (0.00%)
AAPL 195.95 -0.4 (-0.20%)MSFT 133.45 +0.52 (+0.39%)FB 188.78 +0.08 (+0.04%)ZNGA 5.91 -0.04 (-0.59%)NVDA 151.96 -0.17 (-0.11%)WBA 53.16 +0.06 (+0.12%)GOOG 1086.06 +0.02 (+0.00%)PIH 5.3 0 (0.00%)

Financial Statements DOVA Quote Dova Pharma

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Income Statement
Year 20142015201620172018
Revenue 0 0 0 0 0
COGS 0 0 0 0 1
GrossProfit 0 0 0 0 9
Depreciation (included in COGS) 0 0 0 0 0
StockBasedCompe (included in COGS) 0 0 0 6 12
ResearchAndDeve 0 0 0 16 18
SalesGeneralAnd 0 0 0 13 62
OperatingIncome 0 0 0 -29 -71
InterestExpense 0 0 0 1 2
OtherIncome 0 0 0 0 1
IncomeBeforeTax 0 0 0 -30 -72
ProvisionForInc 0 0 0 0 0
NetIncome 0 0 0 -30 -72
Balance Sheet
Year 20142015201620172018
CashAndCashEqui 0 0 29 95 105
ShortTermInvest 0 0 0 0 0
Cash 0 0 29 0 0
AccountReceivab 0 0 0 0 0
Inventories 0 0 0 0 0
DeferredIncomeT 0 0 0 0 0
OtherCurrentAss 0 0 0 0 0
TotalCurrentAss 0 0 29 96 112
PPE 0 0 0 0 0
AccumulatedDepr 0 0 0 0 0
NetPPE 0 0 0 0 0
EquityAndOtherI 0 0 0 0 0
Goodwill 0 0 0 0 0
IntangibleAsset 0 0 0 0 0
OtherLTAssets 0 0 0 0 0
TotalNonCurrent 0 0 0 0 0
TotalAssets 0 0 29 96 112
ShortTermDebt 0 0 0 30 7
AccountsPayable 0 0 0 0 0
TaxesPayable 0 0 0 0 0
AccruedLiabilit 0 0 8 0 0
DeferredRevenue 0 0 0 0 2
OtherCurrentLia 0 0 0 0 2
TotalCurrentLia 0 0 8 35 19
Debt 0 0 14 0 0
DeferredTaxesLi 0 0 0 0 0
DeferredRevenue 0 0 0 0 0
OtherLTLiabilit 0 0 0 0 0
TotalNonCurrent 0 0 14 0 16
TotalLiabilitie 0 0 22 35 36
CommonStock 0 0 0 0 0
AdditionalPaidI 0 0 34 118 206
RetainedEarning 0 0 -27 -57 -129
AccumulatedOthe 0 0 0 0 0
TotalStockholde 0 0 7 61 76
TotalLiabilitie 0 0 29 96 112
Cash Flow Statement
Year 20142015201620172018
NetIncome 0 0 0 -30 -72
Depreciation 0 0 0 0 0
DeferredIncomeT 0 0 0 0 0
StockBasedCompe 0 0 0 6 12
AccountsReceiva 0 0 0 0 -1
InventoryCS 0 0 0 0 -4
AccountsPayable 0 0 0 1 0
OtherWorkingCap 0 0 0 -1 3
OtherNonCashIte 0 0 0 11 1
NetCashProvided 0 0 0 -11 -54
InvestmentsInPP 0 0 0 0 0
AcquisitionsNet 0 0 0 0 0
PurchasesOfInve 0 0 0 0 0
SalesMaturities 0 0 0 0 0
PurchasesOfInta 0 0 0 -1 0
OtherInvestingA 0 0 0 0 0
NetCashUsedForI 0 0 0 -1 0
DebtIssued 0 0 0 0 20
DebtRepayment 0 0 0 0 -31
CommonStockIssu 0 0 0 86 80
CommonStockRepu 0 0 0 0 0
DividendPaid 0 0 0 0 0
OtherFinancingA 0 0 0 -8 -5
NetCashProvided 0 0 0 78 64
NetChangeInCash 0 0 0 66 10
CashAtBeginning 0 0 0 29 95
CashAtEndOfPeri 0 0 0 95 105
Retained Earnings
Year 20142015201620172018
RetainedEarning -----
NetIncome -----
StockDividend ----27
DividendPaid -----
RetainedEarning -----27
Property Plant and Equipment Schedule
Year 20142015201620172018
NetPPE -----
DeprAnnual 0----
CapitalExpendit 00000
NetPPE -----
Intangible and Goodwill Schedule
Year 20142015201620172018
intAndGW 0----
Amortization 0----
NewPurchases 0----
intAndGW -----
Dova Pharmaceuticals Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Dova Pharmaceuticals Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.